Inflammatory Disease Clinical Trials

5 recruiting

Frequently Asked Questions

Common questions about Inflammatory Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

Inflammatory Bowel DiseasesHeart DiseasesAutoimmune Disease+5 more
University of Chicago1,200 enrolled1 locationNCT01280825
Recruiting
Not Applicable

Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer

Cervical CarcinomaEndometrial CarcinomaEndometriosis+1 more
Mayo Clinic120 enrolled3 locationsNCT04567771
Recruiting

Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy

Psoriatic Arthritis (PsA)Rheumatoid Arthritis (RA)Systemic Sclerosis (SSc)+10 more
University of Bonn120 enrolled1 locationNCT07150000
Recruiting

REtinal Markers In Neuroinflammatory Diseases ("REMIND")

Multiple SclerosisNeuroinflammatory Diseases
University Hospital, Basel, Switzerland500 enrolled1 locationNCT06369766
Recruiting
Phase 2

Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV

MicrobiomeHIVCannabis+3 more
University of California, San Diego90 enrolled1 locationNCT05514899
Recruiting

7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of Analgesic Action in Rheumatoid Arthritis

Pain, ChronicRheumatoid ArthritisInflammatory Disease+2 more
NHS Greater Glasgow and Clyde20 enrolled1 locationNCT05697159
Recruiting
Phase 3

InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease

Inflammatory DiseaseBowel DiseaseDisease Crohn
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)158 enrolled1 locationNCT06059989
Recruiting

Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)

Adverse Drug EventDrug UseDrug Side Effect+3 more
Universidade do Porto150 enrolled3 locationsNCT06498167
Recruiting

Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry

Autoimmune DiseasesAutoinflammatory Diseases
Peking Union Medical College Hospital20,000 enrolled9 locationsNCT06417502
Recruiting

Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting

AsthmaVasculitisInflammatory Disease+2 more
Imperial College London120 enrolled1 locationNCT05012033
Recruiting
Not Applicable

Deployment o the Multidisciplinary Prospective Cohort Imminent

Severe AsthmaMultiple SclerosisAtopic Dermatitis+6 more
University Hospital, Lille2,200 enrolled1 locationNCT04334031